Showing 2501-2510 of 3171 results for "".
News
https://practicaldermatology.com/topics/general-topics/news/21281/The Molecular Era in Melanoma Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-molecular-era-in-melanoma-treatment/21296/Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.New Products
https://practicaldermatology.com/columns/new-products/new-products/21316/New Products
https://practicaldermatology.com/columns/new-products/new-products/21337/Medical Costs Skyrocket and New York Times Reporter Finds a Scapegoat
https://practicaldermatology.com/topics/practice-management/medical-costs-skyrocket-and-emnew-york-timesem-reporter-finds-a-scapegoat/21404/Therapeutics Focus: Corticosteroids
https://practicaldermatology.com/topics/psoriasis/therapeutics-focus-corticosteroids/21432/New products and pharmacologic developmentsScurvy in the Modern Era
https://practicaldermatology.com/topics/general-topics/scurvy-in-the-modern-era/21456/One of the winning presentations given by dermatology residents at Cosmetic Surgery Forum.SPF Recommendations: Should They Change?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/spf-recommendations-should-they-change/21475/What is the minimum SPF dermatologists should be recommending to their patients?Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.